Related Experiment Video
Updated: Jan 9, 2026
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules.
Laura A Banaszynski1, Ling-Chun Chen, Lystranne A Maynard-Smith
1Department of Chemistry, Stanford University, Stanford, California 94305, USA.
Scientists developed a new method to control protein stability in cells using synthetic molecules. This technique allows for rapid, reversible, and specific protein regulation, aiding biological research.
Area of Science:
- Molecular Biology
- Biochemistry
- Cell Biology
Background:
- * Precise control over protein function is crucial for understanding complex biological systems.
- * Existing methods for protein perturbation often lack speed, reversibility, or specificity.
Purpose of the Study:
- * To develop a general and controllable method for regulating protein stability in mammalian cells.
- * To enable conditional perturbation of specific proteins using synthetic molecules.
Main Methods:
- * Engineering destabilizing mutants of the human FKBP12 protein.
- * Fusing these destabilizing domains to target proteins of interest.
- * Utilizing cell-permeable synthetic ligands to control protein degradation.
Main Results:
- * Engineered FKBP12 mutants confer rapid and constitutive degradation to fused proteins.
- * Addition of a synthetic ligand reverses degradation, restoring protein function.
- * The system demonstrates specificity, speed, reversibility, and dose-dependence.
Conclusions:
- * This novel strategy provides unprecedented control over protein stability.
- * The method facilitates conditional protein perturbation in various experimental settings.
- * It offers a powerful tool for dissecting biological pathways.
Related Concept Videos
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism I: Introduction
Venous Thrombosis III: Interprofessional Care
Pneumothorax-II
Clinical Manifestations:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation